These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31346082)

  • 21. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
    Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
    Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
    Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
    Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.
    Li X; Chen S; Sun R
    J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
    Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
    Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation.
    Baba Y; Shigemi Z; Hara N; Moriguchi M; Ikeda M; Watanabe T; Fujimuro M
    Int J Oncol; 2018 Feb; 52(2):505-517. PubMed ID: 29207179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.
    Mediani L; Gibellini F; Bertacchini J; Frasson C; Bosco R; Accordi B; Basso G; Bonora M; Calabrò ML; Mattiolo A; Sgarbi G; Baracca A; Pinton P; Riva G; Rampazzo E; Petrizza L; Prodi L; Milani D; Luppi M; Potenza L; De Pol A; Cocco L; Capitani S; Marmiroli S
    Oncotarget; 2016 Feb; 7(5):5521-37. PubMed ID: 26575168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
    Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
    J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus.
    Großkopf AK; Schlagowski S; Hörnich BF; Fricke T; Desrosiers RC; Hahn AS
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
    Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
    Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
    Zhang YJ; Patel D; Nan Y; Fan S
    Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
    Carbone A; Cesarman E; Gloghini A; Drexler HG
    AIDS; 2010 Feb; 24(4):479-90. PubMed ID: 20051807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
    Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
    mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma.
    Lam BQ; Dai L; Li L; Qiao J; Lin Z; Qin Z
    Oncotarget; 2017 Mar; 8(11):18373-18380. PubMed ID: 28407694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
    Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
    Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nigericin Induces Apoptosis in Primary Effusion Lymphoma Cells by Mitochondrial Membrane Hyperpolarization and β-Catenin Destabilization.
    Umeyama H; Shigemi Z; Baba Y; Hara N; Watanabe T; Fujimuro M
    Anticancer Res; 2023 Jun; 43(6):2455-2465. PubMed ID: 37247906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.